Additionally, a mutation in the heme-oxygenase 1 (HMOX1) short (GT)n repeat promoter that confers stronger inducibility of HMOX-1, the rate-limiting enzyme that degrades heme, was associated with a reduction in the rate of hospitalization for ACS in children with SCD [35]. The gene discussed is HMOX1; the disease is Schnyder corneal dystrophy.